Skip to main content
SpringerLink
Log in

A population and family study of CYP1A2 using caffeine urinary metabolites

  • Pharmacokinetics and Disposition
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

CYP1A2 is a cytochrome P450 which is inducible by polycyclic aromatic hydrocarbons. This induction could be mediated via the Ah locus, which encodes a cytosolic receptor responsible for the regulation of the CYP1A1 gene. Enzyme activity in vivo can be measured by the urinary caffeine metabolite ratio (AFMU+1X+1U)/17U. Our goal was to determine, using this ratio, the possible existence of a genetic polymorphism in CYP1A2 induction. For this purpose, a population and family study, including smokers, were undertaken. In a first step, we investigated factors influencing enzyme activity in a population of 245 unrelated individuals.

The induction effect of smoking and inhibiting effect of oral contraceptive use were confirmed. None of the other factors examined (age, sex, level of cigarette consumption, nicotine or tar amounts, filter, inhalation) accounted for the interindividual variability in the metabolic ratio. Using the statistical SKUMIX method, a unimodal (one peak) distribution of the ratio was concluded in 164 unrelated smokers, since a second distribution did not significantly improve the fit to the data (x 21=1.39, P>0.2). Segregation analysis was performed on 68 nuclear families and no major gene effect could be shown. Furthermore, the polygenic model did not provide a higher likelihood than the sporadic one, which argues against the existence of any familial resemblance. Although we cannot rule out the possibility that some environmental factors could obscure the phenotypes and occult a genetic determinism, we conclude that genetic factors are probably negligible in the determination of CYP1A2 activity measured by this method.

These results suggest that CYP1A2 induction via the Ah locus would not be similar to that of CYP1A1.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Butler MA, Guengerich FP, Kadlubar FF (1989) Metabolic activation of the carcinogens 4-aminobiphenyl and 4,4′-methylene-bis (2-chloroaniline) by human hepatic microsomes and purified rat hepatic cytochrome P-450 monooxygenases. Cancer Res 49: 25–31

    Google Scholar 

  2. Pelkonen O, Nebert D (1982) Metabolism of polycyclic aromatic hydrocarbons: etiologic role in carcinogenesis. Pharmacol Rev 34: 189–222

    Google Scholar 

  3. Shimada T, Iwasaki M, Martin MW, Guengerich FP (1989) Human liver microsomal cytochrome P-450 enzymes involved in the bioactivation of procarcinogens detected by umu gene response in Salmonella typhimurium TA 1535/pSK1002. Cancer Res 49: 3218–3228

    Google Scholar 

  4. Pelkonen O (1992) Carcinogen metabolism and individual susceptibility. Scand J Work Environ Health 18 [Suppl 1]: 17–21

    Google Scholar 

  5. Guengerich FP, Shimada T (1991) Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chem Res Toxicol 4: 391–407

    CAS  PubMed  Google Scholar 

  6. Poland A, Glover E, Kende A (1976) Stereospecific, high affinity binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin by hepatic cytosol. Evidence that the binding species is the receptor for the induction of aryl hydrocarbon hydroxylase. J Biol Chem 251: 4936–4946

    Google Scholar 

  7. Hoffman EC, Reyes H, Chu FF, Sander F, Conley LH, Brooks BA, Hankinson O (1991) Cloning of a factor required for activity of the Ah (dioxin) receptor. Science 252: 954–958

    Google Scholar 

  8. Reyes H, Reisz-Porszasz S, Hankinson O (1992) Identification of the Ah receptor nuclear translocator protein (Arnt) as a component of the DNA binding form of the Ah receptor. Science 256: 1193–1195

    Google Scholar 

  9. Denison M, Fisher J, Whitlock J (1988) Inducible, receptor-dependent protein-DNA interactions at a dioxin-responsive transcriptional enhancer. Proc. Natl Acad Sci USA 70: 782–785

    Google Scholar 

  10. Kubota M, Sogawa K, Kaisu Y, Sawaya T, Watanabe J, Kwajiri K, Gotoh O, Fujii-Kuriyama Y (1991) Xenobiotic responsive element in the 5'-upstream region of the human P-450c gene. J Biochem (Tokyo) 110: 232–236

    Google Scholar 

  11. Wu L, Whitlock JP (1993) Mechanism of dioxin action: receptor-enhancer interactions in intact cells. Nucleic Acids Res 21–1: 119–125

    Google Scholar 

  12. Nebert DW, Petersen DD, Puga A (1991) Human AH locus polymorphism and cancer: inducibility of CYPIA1 and other genes by combustion products and dioxin. Pharmacogenetics 1: 68–78

    Google Scholar 

  13. Kellermann G, Cantrell E, Shaw CR (1973) Variations in extent of aryl hydrocarbon hydroxylase induction in cultured human lymphocytes. Cancer Res 33: 1654–1656

    Google Scholar 

  14. Kellermann G, Luyten-Kellermann M, Shaw CR (1973) Genetic variation of aryl hydrocarbon hydroxylase in human lymphocytes. Am J Hum Genet 25: 327–331

    Google Scholar 

  15. Trell L, Korsgaard R, Janzon L, Trell E (1985) Distribution and reproducibility of aryl hydrocarbon hydroxylase inducibility in a prospective population study of middle-aged male smokers and non-smokers. Cancer 56: 1988–1994

    Google Scholar 

  16. Gahmberg CG, Sekki A, Kosunen TU, Holsti LR, Makela O (1979) Induction of aryl hydrocarbon hydroxylase activity and pulmonary carcinoma. Int J Cancer 23: 302–305

    Google Scholar 

  17. Grant DM, Tang BK, Kalow W (1983) Variability in caffeine metabolism. Clin Pharmacol Ther 33: 591–602

    Google Scholar 

  18. Campbell ME, Grant DM, Inaba T, Kalow W (1987) Biotransformation of caffeine, paraxanthine, theophylline, and theobromine by polycyclic aromatic hydrocarbon-inducible cytochromes(s) P-450 in human liver microsomes. Drug Metab Dispos Biol Fate Chem 15: 237–249

    Google Scholar 

  19. Campbell ME, Spielberg SP, Kalow W (1987) A urinary metabolite ratio that reflects systematic caffeine clearance. Clin Pharmacol Ther 42: 157–165

    Google Scholar 

  20. Butler MA, Iwasaki M, Guengerich FP, Kadlubar FF (1989) Human cytochrome P-450 PA (P-4501A2), the phenacetin-O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proc Natl Acad Sci USA 86: 7696–7700

    Google Scholar 

  21. Vistisen K, Loft S, Poulsen HE (1991) Cytochrome P450IA2 activity in man measured by caffeine metabolism: effect of smoking, broccoli and exercise. Adv Exp Med Biol 283: 407–411

    Google Scholar 

  22. Vistisen K, Poulsen HE, Loft S (1992) Foreign compound metabolism capacity in man measured from metabolites of dietary caffeine. Carcinogenesis 13: 1561–1568

    Google Scholar 

  23. Kalow W, Tang BK (1991) Use of caffeine metabolite ratios to explore CYP1A2 and xanthine oxidase activities. Clin Pharmacol Ther 50: 508–519

    Google Scholar 

  24. Kalow W (1991) Caffeine as a metabolic probe: exploration of the enzyme inducing effect of cigarette smoking. Clin Pharmacol Ther 49: 44–48

    Google Scholar 

  25. Kadlubar FF, Talaska G, Butler MA, Teitel CH, Hassengill JP, Lang NP (1990) Determination of carcinogenic arylamine N-oxidation phenotype in humans by analysis of caffeine urinary metabolites. In: Mendelsohn ML, Albertini RJ (eds) Mutation and the environment. Wiley, New York, pp 107–114

    Google Scholar 

  26. Butler MA, Lang NP, Young JF, Caporaso NE, Vineis P, Hayes RB, Teitel CH, Massengill JP, Lawsen MF, Kadlubar FF (1992) Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites. Pharmacogenetics 2: 116–127

    Google Scholar 

  27. Hashiguchi M, Fujimura A, Ohashi K, Ebihara A (1992) Diurnal effect of caffeine clearance. J Clin Pharmacol 32: 184–187

    Google Scholar 

  28. Grant DM (1986) Variability of caffeine biotransformation in man. Thesis, University of Toronto

  29. Tang BK, Zhou Y, Kadar D, Kalow W (1994) Caffeine as a metabolic probe for CYP1A2 activity: potential influence of renal factors on urinary phenotypic trait measurements. Pharmacogenetics 4: 117–124

    Google Scholar 

  30. McLean CJ, Morton NE, Elston RC, Yee S (1976) Skewness in commingled distributions. Biometrics 32: 695–699

    Google Scholar 

  31. Lalouel JM, Rao DC, Morton NE, Elston RC (1983) A unified model for complex segregation analysis. Am J Hum Genet 35: 816–826

    Google Scholar 

  32. Bona%iti-Pellié C, Poisson N, Bechtel Y, Bechtel P (1992) Sensitivity of transmission probabilities to paternity exclusion in segregation analysis. Genet Epidemiol 9: 67–71

    Google Scholar 

  33. Gu L, Gonzalez FJ, Kalow W, Tang BK (1992) Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA expressed human CYP1A2 and CYP2E1. Pharmacogenetics 2: 73–77

    Google Scholar 

  34. Kalow W, Tang BK (1993) The use of caffeine for enzyme assays: a critical appraisal. Clin Pharmacol Ther 53: 503–514

    Google Scholar 

  35. Tucker GT (1994) Determination of drug metabolism status in vivo. Pharmacokinetic and statistical issues. Can J Physiol Pharmacol 72 [Suppl 67]

  36. Wagenknecht LE, Cutter GR, Haley NJ, Sidney S, Manolio TA, Hughes GH, Jacobs DR (1990) Racial differences in serum cotinine levels among smokers in the coronary artery risk development in (young) adults study. Am J Public Health 80: 1053–1056

    Google Scholar 

  37. US Public Health Service (1988): The consequences of smoking: nicotine addiction. DHHS Pub. No. PHS 88. Govt Printing Office, Washington DC, pp 223–672

    CAS  PubMed  Google Scholar 

  38. Pechacek TF, Fox BH, Murray DM, Luepker RV (1984) Review of techniques for measurement of smoking behavior. In: Matarazzo JD, Weiss SM, Herd JA, Miller NE, Weiss SM (eds) Behavioral health: a handbook of health enhancement and disease prevention. Wiley, New York, pp 729–754

    Google Scholar 

  39. Nebert DW, Goujon FM, Gielen JE (1972) Aryl hydrocarbon hydroxylase induction by polycyclic hydrocarbons: simple autosomal dominant trait in the mouse. Nature 236: 107–110

    Google Scholar 

  40. Itoh S, Kamataki T (1993) Human Ah receptor cDNA: analysis for highly conserved sequences. Nucleic Acids Res 21: 3578

    Google Scholar 

  41. Quattrochi LC, Tukey RH (1989) The human cytochrome CYP1A2 gene contains regulatory elements responsive to 3-methylcholanthrene. Mol Pharmacol 36: 66–71

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Unité de Recherches d'Epidémiologie Génétique (U.155 INSERM), Château de Longchamps, Bois de Boulogne, F-75016, Paris, France

    A. Catteau, N. Poisson & C. Bonaïti-Pellié

  2. Service de Pharmacologie Clinique, CHU (Centre Hospitalier Universitaire) Jean Minjoz, F-25030, Besançon Cedex, France

    Y. C. Bechtel & P. R. Bechtel

Authors
  1. A. Catteau
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N. Poisson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Bonaïti-Pellié
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Y. C. Bechtel
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. P. R. Bechtel
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Catteau, A., Poisson, N., Bonaïti-Pellié, C. et al. A population and family study of CYP1A2 using caffeine urinary metabolites. Eur J Clin Pharmacol 47, 423–430 (1995). https://doi.org/10.1007/BF00196856

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00196856

Key words

Search

Navigation